Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emagin Corp (NY: EMAN )

N/A UNCHANGED
Last Price Updated: 8:00 PM EDT, Oct 17, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Emagin Corp

< Previous 1 2 Next >
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Via Benzinga
EMAGIN CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of eMagin Corporation - EMAN
From Kahn Swick & Foti, LLC
Via Business Wire
Beyond the Vision Pro: 3 Augmented Reality Small Caps to Watch
Apple's Vision Pro created a new spark for the virtual and augmented reality industry. Check out three small caps offering potential pure plays on the sector. 
Via MarketBeat
What 4 Analyst Ratings Have To Say About eMagin
Via Benzinga
Why Are eMagin Shares Trading Higher Wednesday
Via Benzinga
EMAGIN CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of eMagin Corporation - EMAN
From Kahn Swick & Foti, LLC
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against eMagin Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
EMAN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of eMagin Corporation Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
A Preview Of eMagin's Earnings
Via Benzinga
eMagin Registers 14% Revenue Growth In Q2 Aided By Military Programs; Expands Margin
Via Benzinga
Here's How eMagin Fared In Q4
eMagin Corp (NYSE: EMAN) reported a fourth-quarter FY21 revenue decline of 6.1% year-on-year to $7.2 million, missing the consensus of $8 million. Segments: ... 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against eMagin Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
12 Information Technology Stocks Moving In Thursday's Intraday Session
Via Benzinga
EMagin Drops After Earnings Miss: CEO Blames Mixed Results On Timing, Delayed Revenue
Electronics components maker eMagin Corp (NYSE: EMAN) reported first-quarter FY23 sales decline of 11% year-on-year to $6.59 million, missing the analyst consensus estimate of $7.56 mil 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Intraday Session
Via Benzinga
Top 5 Tech Stocks That May Fall Off A Cliff This Quarter
The most overbought stocks in the information technology sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Intraday Session
Via Benzinga
eMagin Registers 17% Revenue Growth In Q4 Backed By Robust Bookings; Reports 41% In Gross Margins
Via Benzinga
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the... 
Via Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
Via Benzinga
eMagin's Return on Invested Capital Insights
According to Benzinga Pro, during Q4, eMagin (AMEX:EMAN) earned $1.14 million, a 10.21% increase from the preceding quarter. eMagin also posted a total of $7.21 million in sales,... 
Via Benzinga
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday. 
Via Benzinga
eMagin: Q4 Earnings Insights
eMagin (AMEX:EMAN) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings eMagin... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.